♢ At the end of a title indicates that the FDA has not cleared prescription drugs, approved medical devices and/or biologics for the use described in this presentation. The prescription drugs, approved medical devices and/or biologics are being discussed for an off-label use.

Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Name
      Event Title
        Event Type
          Category-Classification
            Event Day

              240 Low-Volume Surgeons Operating at High-Volume Hospitals Have Low Rates of Periprosthetic Joint Infection after Hip and Knee Arthroplasty

              Author:Julian Wier, MD  Ryan Palmer, BS  Sagar Telang, BS  Andrew Dobitsch, MD  Nathanael Heckmann, MD, FAAOS  Jay Lieberman, MD,FAAOS  

              Event Title:(230-241) VIPER: Adult Reconstruction Hip III Papers  

              Event Type:Paper Presentations  

              Category-Classification:Adult Reconstruction Hip  

              Event Day:Tuesday, March 11  

              e041 Perioperative Tranexamic Acid Should be Considered for Total Joint Arthroplasty Patients Receiving Apixaban for Thromboprophylaxis

              Author:Sagar Telang, BS  Ryan Palmer, BS  Andrew Dobitsch, MD  Jacob Ball, MD  Nathanael Heckmann, MD, FAAOS  Jay Lieberman, MD,FAAOS  

              Event Title:e001-e150 Adult Reconstruction Hip ePosters  

              Event Type:ePosters  

              Category-Classification:Adult Reconstruction Hip  

              Event Day:Monday, March 10